MP

Mike Panesis

North America, California, United States, Camarillo

Description

Mike Panesis is the Steven Dorfman Professor of Practice at California Lutheran University. Attended Rutgers Business School.

Investor Profile

Mike Panesis has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (25%)
  • Convertible Note (25%)
  • Seed (25%)
  • Debt Financing (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Software
  • Edtech
  • Education
  • Private Social Networking
  • Saas
  • Sports
  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mike Panesis frequently co-invest with?

GH
North America, California, United States, Santa Barbara
Co-Investments: 1
SS
North America, California, United States, San Luis Obispo
Co-Investments: 1
Pasadena Angels
North America, California, United States, Altadena
Co-Investments: 1
Frontier Venture Capital
North America, Usulutan, El Salvador, California
Co-Investments: 1
Rosecliff Ventures
North America, New York, United States, New York
Co-Investments: 1
Tech Coast Angels
North America, California, United States, Newport Beach
Co-Investments: 2

What are some of recent deals done by Mike Panesis?

Edufii

Mill Valley, California, United States

Edufii develops and operates a cloud-based coaching platform and skill development network.

EdTechEducationPrivate Social NetworkingSaaSSports
Series ASep 9, 2014
Amount Raised: $1,400,000
Riptide IO

Santa Barbara, California, United States

Riptide IO helps large enterprises navigate the transition to an internet-based, data-driven world of integrated device management.

AnalyticsBig DataInformation TechnologySoftware
Debt FinancingJul 28, 2014
Amount Raised: $400,000
Adero

Goleta, California, United States

Adero is an intelligent organization system that helps people to find or locate their misplaced items.

Consumer ElectronicsHardwareInternet of ThingsMobileSoftwareWireless
SeedJul 1, 2011
CytomX Therapeutics

South San Francisco, California, United States

CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Convertible NoteMar 3, 2010
Amount Raised: $2,500,000